Lorraine Jones-Brando

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii
    Lorraine Jones-Brando
    Stanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins University School of Medicine, 600 N Wolfe Street Blalock 1149, Baltimore, MD 21287 4933, USA
    Schizophr Res 62:237-44. 2003
  2. ncbi In vitro inhibition of Toxoplasma gondii by four new derivatives of artemisinin
    Lorraine Jones-Brando
    Stanley Division of Developmental Neurovirology, Dept of Pediatrics, Johns Hopkins University School of Medicine, 600 N Wolfe St, Baltimore, MD 21287 4988, USA
    Antimicrob Agents Chemother 50:4206-8. 2006
  3. ncbi Transactivation of elements in the human endogenous retrovirus W family by viral infection
    Christoffer Nellåker
    The Department of Neuroscience, Karolinska Institutet, Retzius vag 8, 171 77 Stockholm, Sweden
    Retrovirology 3:44. 2006
  4. ncbi Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle
    John G D'Angelo
    Department of Chemistry and The Malaria Research Institute, Johns Hopkins University, 3400 N Charles St, Baltimore, MD 21218, USA
    J Antimicrob Chemother 63:146-50. 2009
  5. ncbi Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii
    Christopher P Hencken
    Department of Chemistry, The Johns Hopkins University, 3400 North Charles Street, Baltimore, Maryland 21218, USA
    J Med Chem 53:3594-601. 2010
  6. ncbi Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers
    Ravit Arav-Boger
    Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
    PLoS ONE 5:e10370. 2010
  7. ncbi Differential effects of three canonical Toxoplasma strains on gene expression in human neuroepithelial cells
    Jianchun Xiao
    Stanley Division of Developmental Neurovirology, Johns Hopkins School of Medicine, 600 N Wolfe Street, 1105 Blalock, Baltimore, MD 21287 4933, USA
    Infect Immun 79:1363-73. 2011
  8. ncbi Inhibition of Toxoplasma gondii by indirubin and tryptanthrin analogs
    Bogdana Krivogorsky
    Dept of Pediatrics, Johns Hopkins University School of Medicine, 600 N Wolfe St, Baltimore, MD 21287, USA
    Antimicrob Agents Chemother 52:4466-9. 2008
  9. ncbi Toxoplasma gondii strain-dependent effects on mouse behaviour
    Geetha Kannan
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287 5371, USA
    Folia Parasitol (Praha) 57:151-5. 2010

Collaborators

Detail Information

Publications9

  1. ncbi Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii
    Lorraine Jones-Brando
    Stanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins University School of Medicine, 600 N Wolfe Street Blalock 1149, Baltimore, MD 21287 4933, USA
    Schizophr Res 62:237-44. 2003
    ..Several medications used to treat schizophrenia and bipolar disorder have the ability to inhibit the in vitro replication of T. gondii...
  2. ncbi In vitro inhibition of Toxoplasma gondii by four new derivatives of artemisinin
    Lorraine Jones-Brando
    Stanley Division of Developmental Neurovirology, Dept of Pediatrics, Johns Hopkins University School of Medicine, 600 N Wolfe St, Baltimore, MD 21287 4988, USA
    Antimicrob Agents Chemother 50:4206-8. 2006
    ..We synthesized novel, nonacetal, hydrolytically stable derivatives of artemisinin and showed that they inhibit the replication of Toxoplasma gondii in cell culture...
  3. ncbi Transactivation of elements in the human endogenous retrovirus W family by viral infection
    Christoffer Nellåker
    The Department of Neuroscience, Karolinska Institutet, Retzius vag 8, 171 77 Stockholm, Sweden
    Retrovirology 3:44. 2006
    ....
  4. ncbi Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle
    John G D'Angelo
    Department of Chemistry and The Malaria Research Institute, Johns Hopkins University, 3400 N Charles St, Baltimore, MD 21218, USA
    J Antimicrob Chemother 63:146-50. 2009
    ....
  5. ncbi Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii
    Christopher P Hencken
    Department of Chemistry, The Johns Hopkins University, 3400 North Charles Street, Baltimore, Maryland 21218, USA
    J Med Chem 53:3594-601. 2010
    ..Some of the new derivatives of artemisinin described here represent effective anti-Toxoplasma trioxanes as well as molecular probes for elucidating the mechanism of action of the DART class of artemisinin derivatives...
  6. ncbi Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers
    Ravit Arav-Boger
    Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
    PLoS ONE 5:e10370. 2010
    ..Artesunate, an artemisinin-derived monomer, was reported to inhibit Cytomegalovirus (CMV) replication. We aimed to compare the in-vitro anti-CMV activity of several artemisinin-derived monomers and newly synthesized artemisinin dimers...
  7. ncbi Differential effects of three canonical Toxoplasma strains on gene expression in human neuroepithelial cells
    Jianchun Xiao
    Stanley Division of Developmental Neurovirology, Johns Hopkins School of Medicine, 600 N Wolfe Street, 1105 Blalock, Baltimore, MD 21287 4933, USA
    Infect Immun 79:1363-73. 2011
    ..These observed differences may explain some of the variation in the neurobiological effects of different strains of Toxoplasma on infected individuals...
  8. ncbi Inhibition of Toxoplasma gondii by indirubin and tryptanthrin analogs
    Bogdana Krivogorsky
    Dept of Pediatrics, Johns Hopkins University School of Medicine, 600 N Wolfe St, Baltimore, MD 21287, USA
    Antimicrob Agents Chemother 52:4466-9. 2008
    ..Indirubin-3'-oxime analogs showed modest micromolar activity, while tryptanthrin derivatives displayed 50% inhibitory doses in the low nanomolar range. Tryptanthrins have potential as anti-Toxoplasma infection therapeutics...
  9. ncbi Toxoplasma gondii strain-dependent effects on mouse behaviour
    Geetha Kannan
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287 5371, USA
    Folia Parasitol (Praha) 57:151-5. 2010
    ..No differences in parasite antibody titres were seen between PRU- and ME49-infected mice. The present data suggest the effect of T. gondii infection on mouse behaviour is parasite strain-dependent...